15,97 €
18,79 €
-15% su kodu: ENG15
Bad Blood
15,97 € 
- Išsiųsime per 10–14 d.d.
Now with a new afterword covering the months-long landmark trials of Elizabeth Holmes and Sunny Balwani.‘I couldn’t put down this thriller . . . the perfect book to read by the fire this winter.’ Bill GatesWinner of the Financial Times/McKinsey Business Book of the Year Award 2018The riveting true story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, by the prize-winning journalist who first broke the story and pur…
15.97
2025-07-27 23:59:00
/https://libri-media.knygos-static.lt/962baacc-bbee-4e7e-96d9-285f3ac2fcc9/4)
- Autorius: John Carreyrou
- Leidėjas: Pan Macmillan
- Metai: 2023
- Puslapiai: 400
- ISBN-10: 1035006774
- ISBN-13: 9781035006779
- Formatas: 12.7 x 19.4 x 2.7 cm, minkšti viršeliai
- Kalba: Anglų
- Extra -15 % nuolaida šiai knygai su kodu: ENG15
Atsiliepimai
Aprašymas
Now with a new afterword covering the months-long landmark trials of Elizabeth Holmes and Sunny Balwani.‘I couldn’t put down this thriller . . . the perfect book to read by the fire this winter.’ Bill Gates
Winner of the Financial Times/McKinsey Business Book of the Year Award 2018
The riveting true story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve a brilliant Stanford dropout whose startup ‘unicorn’ promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one the technology didn’t work.
In Bad Blood , John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
‘Chilling . . . Reads like a West Coast version of All the President’s Men .’ New York Times Book Review
EXTRA 15 % nuolaida su kodu: ENG15
15,97 €
18,79 €
Išsiųsime per 10–14 d.d.
Akcija baigiasi už 6d.14:14:28
Nuolaidos kodas galioja perkant nuo 10 €. Nuolaidos nesumuojamos.
- Autorius: John Carreyrou
- Leidėjas: Pan Macmillan
- Metai: 2023
- Puslapiai: 400
- ISBN-10: 1035006774
- ISBN-13: 9781035006779
- Formatas: 12.7 x 19.4 x 2.7 cm, minkšti viršeliai
- Kalba: Anglų
Now with a new afterword covering the months-long landmark trials of Elizabeth Holmes and Sunny Balwani.
‘I couldn’t put down this thriller . . . the perfect book to read by the fire this winter.’ Bill Gates
Winner of the Financial Times/McKinsey Business Book of the Year Award 2018
The riveting true story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve a brilliant Stanford dropout whose startup ‘unicorn’ promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one the technology didn’t work.
In Bad Blood , John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
‘Chilling . . . Reads like a West Coast version of All the President’s Men .’ New York Times Book Review
‘I couldn’t put down this thriller . . . the perfect book to read by the fire this winter.’ Bill Gates
Winner of the Financial Times/McKinsey Business Book of the Year Award 2018
The riveting true story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve a brilliant Stanford dropout whose startup ‘unicorn’ promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one the technology didn’t work.
In Bad Blood , John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
‘Chilling . . . Reads like a West Coast version of All the President’s Men .’ New York Times Book Review
Atsiliepimai